HER-2 cancer vaccine (L2 Diagnostics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHER-2 cancer vaccine (L2 Diagnostics)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesL2 Diagnostics LLC

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesL2 Diagnostics LLC

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A